Sodium Alginate Diester Tablets

Pharmacological studies and clinical trials have shown that this product has strong dispersing and emulsifying properties and is not affected by external factors. Because it has a linear structure of anionic polyelectrolyte, it can increase the negative charge on the surface of red blood cells, enhance mutual repulsion, and resist adhesion between red blood cells or between red blood cells and blood vessel walls, thus significantly reducing blood viscosity and having an anticoagulant effect. Its efficacy is equivalent to 1/3-1/2 of heparin, and it has obvious functions of lowering blood lipids, dilating blood vessels, lowering blood pressure and blood sugar. This product has high efficacy, low toxicity, good oral absorption, and can be used as a therapeutic and preventive drug.

Sodium alginate is synthesized by introducing effective groups from alginate as the basic raw material by chemical methods. It is a linear anionic polyelectrolyte with heparin-like physiological activity but no heparin-like toxic side effects. It is a new type of heparin-like marine drug.

This product is a sugar-coated tablet, which is slightly yellow after removing the sugar coating.

This product is mainly used for the prevention and treatment of ischemic cardiovascular and cerebrovascular diseases, such as cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, hyperlipidemia, hypertension, stroke and coronary heart disease. In addition, this product has obvious effects on the treatment of disseminated intravascular coagulation and chronic glomerulonephritis. This product is used in combination with immunosuppressants to treat the infectious disease epidemic hemorrhagic fever and achieve satisfactory results.

Oral, 1-2 tablets at a time, three times a day or as directed by your doctor.

The incidence of adverse reactions is 5% to 23%, which may include fever, leukopenia and thrombocytopenia, low blood pressure, abnormal liver function and electrocardiogram, uterine or subconjunctival hemorrhage, allergic reaction, headache, palpitations, irritability, fatigue, drowsiness, etc.

It is contraindicated for patients with a history of bleeding, hemophilia, cerebral hemorrhage, and severe liver or kidney dysfunction.

Not yet clear.

Keep away from light and store in airtight container.

50mg

Shanxi Jinhuahuixing Pharmaceutical. Co., Ltd.

• Founded in:

  2004-04-23

• Address:

  No. 8 Fengxiang Road, Qingjian Street, Hejin City, Yuncheng City, Shanxi Province

• Tax NO.:

  911408007572846589

• Registered Funds:

  33.6 million yuan

• Website:

  Log in to view

• Email:

  Log in to view